Xiaojing Liu

机构：Tongji University, Second Military Medical University, Shanghai Jiao Tong University, Peking University, National Health and Family Planning Commission, Hainan Maternal and Child Health Hospital, National Clinical Research Center for Digestive Diseases, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Shanghai Skin Disease Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0009-0000-3637-0917

发表论文 96 篇 · 总被引 1026 次 · h-index 18

代表论文

• Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism (2023 · Redox Biology · 被引 25)
• Prevalence and risk factors of atopic dermatitis in Chinese adults: a nationwide population-based cross-sectional study (2023 · Chinese Medical Journal · 被引 20)
• Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice (2024 · Acta Pharmacologica Sinica · 被引 18)
• Subclinical left ventricular deformation and microvascular dysfunction in T2DM patients with and without peripheral neuropathy: assessed by 3.0 T cardiac magnetic resonance imaging (2023 · Cardiovascular Diabetology · 被引 17)
• Whole process establishment of carrier-free 177Lu production: from small-scale production to pilot-scale production (2023 · Journal of Radioanalytical and Nuclear Chemistry · 被引 8)
• Limosilactobacillus reuteri-butyrate axis in depression therapy: A key pathway discovered through a novel preclinical human flora-associated animal model (2025 · Pharmacological Research · 被引 7)